Literature DB >> 28747446

Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia.

Alberto Benussi1, Francesco Di Lorenzo1, Valentina Dell'Era1, Maura Cosseddu1, Antonella Alberici1, Salvatore Caratozzolo1, Maria Sofia Cotelli1, Anna Micheli1, Luca Rozzini1, Alessandro Depari1, Alessandra Flammini1, Viviana Ponzo1, Alessandro Martorana1, Carlo Caltagirone1, Alessandro Padovani1, Giacomo Koch2, Barbara Borroni2.   

Abstract

OBJECTIVE: To determine whether a transcranial magnetic stimulation (TMS) multiparadigm approach can be used to distinguish Alzheimer disease (AD) from frontotemporal dementia (FTD).
METHODS: Paired-pulse TMS was used to investigate short-interval intracortical inhibition (SICI) and facilitation (ICF), long-interval intracortical inhibition, and short-latency afferent inhibition (SAI) to measure the activity of different intracortical circuits in patients with AD, patients with FTD, and healthy controls (HC). The primary outcome measures were sensitivity and specificity of TMS measures, derived from receiver operating curve analysis.
RESULTS: A total of 175 participants met the inclusion criteria. We diagnosed 79 patients with AD, 64 patients with FTD, and 32 HC. We found that while patients with AD are characterized by a specific impairment of SAI, FTD shows a remarkable dysfunction of SICI-ICF intracortical circuits. With the use of the best indexes, TMS differentiated FTD from AD with a sensitivity of 91.8% and specificity of 88.6%, AD from HC with a sensitivity of 84.8% and specificity of 90.6%, and FTD from HC with a sensitivity of 90.2% and specificity of 78.1%. These results were confirmed in patients with mild disease.
CONCLUSIONS: TMS is a noninvasive procedure that reliably distinguishes AD from FTD and HC and, if these findings are replicated in larger studies, could represent a useful additional diagnostic tool for clinical practice. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that TMS measures can distinguish patients with AD from those with FTD.
© 2017 American Academy of Neurology.

Entities:  

Mesh:

Year:  2017        PMID: 28747446     DOI: 10.1212/WNL.0000000000004232

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

Review 1.  Transcranial Magnetic Stimulation as Treatment in Multiple Neurologic Conditions.

Authors:  Antonio H Iglesias
Journal:  Curr Neurol Neurosci Rep       Date:  2020-02-04       Impact factor: 5.081

Review 2.  Therapeutic noninvasive brain stimulation in Alzheimer's disease and related dementias.

Authors:  Stephanie S Buss; Peter J Fried; Alvaro Pascual-Leone
Journal:  Curr Opin Neurol       Date:  2019-04       Impact factor: 5.710

3.  Older adults' episodic memory is related to a neurophysiological marker of brain cholinergic activity.

Authors:  Patrick S R Davidson; Galit Karpov; Lauriane Giguère; Alex W Castro; François Tremblay
Journal:  Exp Brain Res       Date:  2022-07-30       Impact factor: 2.064

Review 4.  Toward noninvasive brain stimulation 2.0 in Alzheimer's disease.

Authors:  Arianna Menardi; Simone Rossi; Giacomo Koch; Harald Hampel; Andrea Vergallo; Michael A Nitsche; Yaakov Stern; Barbara Borroni; Stefano F Cappa; Maria Cotelli; Giulio Ruffini; Georges El-Fakhri; Paolo M Rossini; Brad Dickerson; Andrea Antal; Claudio Babiloni; Jean-Pascal Lefaucheur; Bruno Dubois; Gustavo Deco; Ulf Ziemann; Alvaro Pascual-Leone; Emiliano Santarnecchi
Journal:  Ageing Res Rev       Date:  2021-12-30       Impact factor: 11.788

5.  Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.

Authors:  Smriti Agarwal; Elizabeth Highton-Williamson; Jashelle Caga; José M Matamala; Thanuja Dharmadasa; James Howells; Margaret C Zoing; Kazumoto Shibuya; Nimeshan Geevasinga; Steve Vucic; John R Hodges; Rebekah M Ahmed; Matthew C Kiernan
Journal:  J Neurol       Date:  2018-06-04       Impact factor: 4.849

Review 6.  Recent neuroimaging, neurophysiological, and neuropathological advances for the understanding of NPC.

Authors:  Alberto Benussi; Maria Sofia Cotelli; Alessandro Padovani; Barbara Borroni
Journal:  F1000Res       Date:  2018-02-15

Review 7.  Non-invasive Brain Stimulation: Probing Intracortical Circuits and Improving Cognition in the Aging Brain.

Authors:  Joyce Gomes-Osman; Aprinda Indahlastari; Peter J Fried; Danylo L F Cabral; Jordyn Rice; Nicole R Nissim; Serkan Aksu; Molly E McLaren; Adam J Woods
Journal:  Front Aging Neurosci       Date:  2018-06-08       Impact factor: 5.750

8.  A Systematic Review of Long-Interval Intracortical Inhibition as a Biomarker in Neuropsychiatric Disorders.

Authors:  Parmis Fatih; M Utku Kucuker; Jennifer L Vande Voort; Deniz Doruk Camsari; Faranak Farzan; Paul E Croarkin
Journal:  Front Psychiatry       Date:  2021-06-02       Impact factor: 4.157

9.  The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease.

Authors:  Alberto Benussi; Antonella Alberici; Clarissa Ferrari; Valentina Cantoni; Valentina Dell'Era; Rosanna Turrone; Maria Sofia Cotelli; Giuliano Binetti; Barbara Paghera; Giacomo Koch; Alessandro Padovani; Barbara Borroni
Journal:  Alzheimers Res Ther       Date:  2018-09-18       Impact factor: 6.982

10.  Clinical and neurophysiological characteristics of heterozygous NPC1 carriers.

Authors:  Alberto Benussi; Maria S Cotelli; Valentina Cantoni; Valeria Bertasi; Marinella Turla; Andrea Dardis; Jessica Biasizzo; Rosa Manenti; Maria Cotelli; Alessandro Padovani; Barbara Borroni
Journal:  JIMD Rep       Date:  2019-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.